Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurel K Berry

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Gynecologic Oncology Reports|June 24, 2024
IgG4-related disease in the pelvis: A mimicker of gynecologic malignancyKristen Stearns, Binathi Vuppuluri, Ruth Lininger, et al.
Urology Case Reports|September 27, 2023
Transvaginal ureteroneocystostomyLaurel K Berry, Collin M McKenzie, Samuel S Lentz
Gynecologic Oncology Reports|August 27, 2024
Endometrial cancer recurrence after the use of a uterine manipulator during laparoscopic surgeryJessica M Souza, Kristen Stearns, Fang-Chi Hsu, et al.
Gynecologic Oncology|June 27, 2026
A second chance for the second look: Feasibility of laparoscopic HIPEC at the conclusion of upfront treatment for epithelial ovarian cancerAna Kouri, Anya Menzies, Kristen Stearns, et al.
Gynecologic Oncology|April 12, 2020
Take me to your leader: Reporting structures and equity in academic gynecologic oncologySarah M Temkin, Lisa Rubinsak, Michelle F Benoit, et al.
American Journal of Obstetrics and Gynecology|May 29, 2026
2026 International Society for the Study of Vulvovaginal Disease (ISSVD) terminology for vulvar intraepithelial neoplasia and squamous intraepithelial lesionsTania Day, James Scurry, Carlos Parra-Herran, et al.
Journal of Translational Medicine|November 20, 2024
A patient stratification signature mirrors the immunogenic potential of high grade serous ovarian cancersLaurel K Berry, Ashok K Pullikuth, Kristen L Stearns, et al.
Annals of Surgical Oncology|April 15, 2024
Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH-Sensitive Imaging Agent: Final Results from a Phase II StudyPatrick Wagner, Edward A Levine, Alex C Kim, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Gynecologic Oncology Reports|June 24, 2024
IgG4-related disease in the pelvis: A mimicker of gynecologic malignancyKristen Stearns, Binathi Vuppuluri, Ruth Lininger, et al.
Urology Case Reports|September 27, 2023
Transvaginal ureteroneocystostomyLaurel K Berry, Collin M McKenzie, Samuel S Lentz
Gynecologic Oncology Reports|August 27, 2024
Endometrial cancer recurrence after the use of a uterine manipulator during laparoscopic surgeryJessica M Souza, Kristen Stearns, Fang-Chi Hsu, et al.
Gynecologic Oncology|June 27, 2026
A second chance for the second look: Feasibility of laparoscopic HIPEC at the conclusion of upfront treatment for epithelial ovarian cancerAna Kouri, Anya Menzies, Kristen Stearns, et al.
Gynecologic Oncology|April 12, 2020
Take me to your leader: Reporting structures and equity in academic gynecologic oncologySarah M Temkin, Lisa Rubinsak, Michelle F Benoit, et al.
American Journal of Obstetrics and Gynecology|May 29, 2026
2026 International Society for the Study of Vulvovaginal Disease (ISSVD) terminology for vulvar intraepithelial neoplasia and squamous intraepithelial lesionsTania Day, James Scurry, Carlos Parra-Herran, et al.
Journal of Translational Medicine|November 20, 2024
A patient stratification signature mirrors the immunogenic potential of high grade serous ovarian cancersLaurel K Berry, Ashok K Pullikuth, Kristen L Stearns, et al.
Annals of Surgical Oncology|April 15, 2024
Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH-Sensitive Imaging Agent: Final Results from a Phase II StudyPatrick Wagner, Edward A Levine, Alex C Kim, et al.
Pageof 1